Address
CMEA Capital
One Embarcadero Center
Suite 3250
San Francisco, CA 94111
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 29362
Corporate information
Founders
Also known as
CMEA Ventures
Chemical and Materials Enterprise Associates
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| CMEA Ventures VI LP | Venture |
Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
|
Chevron Technology Ventures LLC (CTV) | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
Investment activity status
Active investor
Selected investments
Displaying 1 - 50 of 53| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Apriso Corp | Provider of enterprise software solutions | N/A | |||
|
|
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | |||
|
|
Codexis Inc | Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. | N/A | |||
|
|
Codexis Inc | Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. | Series D | |||
|
|
Draths Corp | N/A | ||||
|
|
Entropic Communications Inc | Provider of silicon and software solutions to enable connected home entertainment. | N/A | |||
|
|
InSound Medical Inc | Medical device company focused on the development and sale of next generation hearing aid solutions. | Series E | |||
|
|
LiveOps Inc | Series B | ||||
|
|
Luminus Devices Inc | Development and manufacturing of high performance solid state light sources for a variety of illumination applications | Series E | |||
|
|
Quantum Dot Corp | N/A | ||||
|
|
Raven Biotechnologies Inc | A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. | N/A | |||
|
|
Relypsa Inc | Leads the discovery and development of new non-absorbed polymeric drugs | Series A | |||
|
|
Rigel Pharmaceuticals Inc | N/A | ||||
|
|
Sanera Systems Inc | Series A | ||||
|
|
Schooner Information Technology Inc | Enterprise storage software company. | Series B | |||
|
|
Solaria Corp | Low concentration PV modules | Series D | |||
|
|
SpikeSource Inc | Open source focused, software certification company. | Series C | |||
|
|
Strix Systems Inc | N/A | ||||
|
|
Strix Systems Inc | Series B | ||||
|
|
Surgiquest Inc | Developer, manufacturer and marketer of innovative access technology for minimally invasive surgery. | N/A | |||
|
|
Symwave | Developer and marketer of high-performance analog/mixed-signal integrated circuits and system solutions. | Series C | |||
|
|
Symyx Technologies | Develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications. | N/A | |||
|
|
Syrrx Inc | Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma | N/A | |||
|
|
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | Series B | |||
|
|
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | Series A | |||
|
|
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | Series C | |||
|
|
VasoNova Inc | Leader in algorithm-based vascular navigation and measurement technology. | Series B | |||
|
|
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Series D | |||
|
0-In Design Automation Inc | Provider of verification products that help verify multi-million gate ASICs and SOC designs. | N/A | |||
|
|
Aclara Biosciences Inc | Develops and distributes assay solutions for drug discovery and development | N/A | |||
|
|
Aerogen | Medical device and drug delivery company | N/A | |||
|
|
AirTight Networks Inc | Provider of comprehensive Wi-Fi intrusion detection, wireless LAN planning, monitoring, and security solutions. | Series C | |||
|
Alien Technology Corp | Radio Frequency Identification (RFID) services and products. | N/A | |||
|
|
Arcadia Biosciences Inc | N/A | ||||
|
|
Auspex Pharmaceuticals Inc | Series B | ||||
|
|
Auspex Pharmaceuticals Inc | Series C | ||||
|
|
Baxano Inc | A medical device company focused on developing minimally invasive tools to restore spine function and preserve healthy tissue. | Series C | |||
|
Blekko Inc | Provide a differentiated editorial voice in search | Series B | |||
|
|
Blekko Inc | Provide a differentiated editorial voice in search | Series C | |||
|
|
Blekko Inc | Provide a differentiated editorial voice in search | N/A | |||
|
Contour Energy Systems Inc | Developer of primary and rechargeable batteries enabled by nanotechnology. | Series C Initial investment | |||
|
|
Danotek Motion Technologies | A Canton, Michigan - based developer of generators and components to supply wind energy to the power grid | Series B | |||
|
Ensemble Therapeutics Corp | N/A | ||||
|
|
Foro Energy Inc | Manufactures and commercializes high power lasers for oil, natural gas, geothermal, and mining industries in the United States and internationally. | N/A | |||
|
|
Intellikine | Series B | ||||
|
|
Intermolecular Inc | Series C | ||||
|
|
Intermolecular Inc | Series D | ||||
|
Luminate Inc | Web-based company that makes images interactive. | Series C | |||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A | |||
|
|
Solaria Corp | Low concentration PV modules | Debt |
Current team
| Employee | Position | ||
|---|---|---|---|
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/_person_0.png?itok=nkWWtsDD){kind=icon}
|
David J Collier | ||
|
|
Brett Cummings | ||
|
|
Maurice E P Gunderson | ||
|
|
John L Haag | ||
|
|
Karl D Handelsman | ||
|
|
Jim Hornthal | ||
|
|
Saad Khan | ||
|
|
Faysal A Sohail | ||
|
|
James F Watson |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
|
|
Thomas Baruch (founder) | Formation8 Partners LLC | ||
|
|
Thomas Baruch (founder) | M34 Capital Inc | ||
|
|
Jim Kim | Formation8 Partners LLC | ||
|
|
Jim Kim | Builders VC | Founder
From |
|
|
Rachel Sheinbein | Lemnos Labs |